• 2749 Citations
  • 25 Scopus h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mei-Yin Polley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
temozolomide Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Glioma Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 2749 Citations
  • 25 Scopus h-Index
  • 35 Article
  • 5 Review article
  • 3 Letter
2 Citations (Scopus)

Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations

Peterson, J. F., Rowsey, R. A., Marcou, C. A., Pearce, K. E., Williamson, C. M., Frederick, L. A., Greipp, P. T., Ketterling, R. P., Kumar, S. K., Viswanatha, D. S., Polley, M-Y., Fink, J. M., Reichard, K. K., Van Dyke, D. L. & Baughn, L., Mar 1 2019, In : Blood cancer journal. 9, 3, 20.

Research output: Contribution to journalLetter

Monosomy
Multiple Myeloma
Mutation
1 Citation (Scopus)

Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 + T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma

Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Price-Troska, T., Jalali, S., Wu, H., Luchtel, R. A., Polley, M-Y., Novak, A. J. & Ansell, S. M., Feb 19 2019, In : Cell reports. 26, 8, p. 2178-2193.e3

Research output: Contribution to journalArticle

Open Access
Follicular Lymphoma
T-cells
T-Lymphocyte Subsets
T-Lymphocytes
Survival
7 Citations (Scopus)
Paraproteinemias
Multiple Myeloma
Precision Medicine
Genetic Predisposition to Disease
Cytogenetics
10 Citations (Scopus)

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

Leon-Ferre, R. A., Polley, M-Y., Liu, H., Gilbert, J. A., Cafourek, V., Hillman, D. W., Elkhanany, A., Akinhanmi, M., Lilyquist, J., Thomas, A., Negron, V., Boughey, J. C., Liu, M. C., Ingle, J. N., Kalari, K. R., Couch, F. J., Visscher, D. W. & Goetz, M. P., Sep 14 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Tumor-Infiltrating Lymphocytes
Adjuvant Chemotherapy
Disease-Free Survival
Survival

Power estimation in biomarker studies where events are already observed

Polley, M-Y., Dec 1 2017, In : Clinical Trials. 14, 6, p. 621-628 8 p.

Research output: Contribution to journalArticle

Biomarkers
Tumor Biomarkers
Sample Size
Software
Randomized Controlled Trials